43 results on '"Eliott S"'
Search Results
2. Methods for the preparation and analysis of the diterpene cyclase fusicoccadiene synthase
- Author
-
Wenger, Eliott S., primary and Christianson, David W., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Engineering substrate channeling in a bifunctional terpene synthase.
- Author
-
Wenger, Eliott S., Schultz, Kollin, Marmorstein, Ronen, and Christianson, David W.
- Subjects
- *
CATALYTIC domains , *PROTEIN engineering , *BIOCHEMICAL substrates , *CYCLASES , *DIMETHYLALLYLTRANSTRANSFERASE - Abstract
Fusicoccadiene synthase from Phomopsis amygdala (PaFS) is a bifunctional terpene synthase. It contains a prenyltransferase (PT) domain that generates geranylgeranyl diphosphate (GGPP) from dimethylallyl diphosphate and three equivalents of isopentenyl diphosphate, and a cyclase domain that converts GGPP into fusicoccadiene, a precursor of the diterpene glycoside Fusicoccin A. The two catalytic domains are connected by a flexible 69-residue linker. The PT domain mediates oligomerization to form predominantly octamers, with cyclase domains randomly splayed out around the PT core. Surprisingly, despite the random positioning of cyclase domains, substrate channeling is operative in catalysis since most of the GGPP generated by the PT remains on the enzyme for cyclization. Here, we demonstrate that covalent linkage of the PT and cyclase domains is not required for GGPP channeling, although covalent linkage may improve channeling efficiency. Moreover, GGPP competition experiments with other diterpene cyclases indicate that the PaFS PT and cyclase domains are preferential partners regardless of whether they are covalently linked or not. The cryoelectron microscopy structure of the 600-kD "linkerless" construct, in which the 69-residue linker is spliced out and replaced with the tripeptide PTQ, reveals that cyclase pairs associate with all four sides of the PT octamer and exhibit fascinating quaternary structural flexibility. These results suggest that optimal substrate channeling is achieved when a cyclase domain associates with the side of the PT octamer, regardless of whether the two domains are covalently linked and regardless of whether this interaction is transient or locked in place. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Optimized Substrate Positioning Enables Switches in the C–H Cleavage Site and Reaction Outcome in the Hydroxylation–Epoxidation Sequence Catalyzed by Hyoscyamine 6β-Hydroxylase.
- Author
-
Wenger, Eliott S., Martinie, Ryan J., Ushimaru, Richiro, Pollock, Christopher J., Sil, Debangsu, Li, Aaron, Hoang, Nhi, Palowitch, Gavin M., Graham, Brandt P., Schaperdoth, Irene, Burke, Evan J., Maggiolo, Ailiena O., Chang, Wei-chen, Allen, Benjamin D., Krebs, Carsten, Silakov, Alexey, Boal, Amie K., and Bollinger Jr., J. Martin
- Published
- 2024
- Full Text
- View/download PDF
5. An Unusual Ferryl Intermediate and Its Implications for the Mechanism of Oxacyclization by the Loline-Producing Iron(II)- and 2‑Oxoglutarate-Dependent Oxygenase, LolO.
- Author
-
Pan, Juan, Wenger, Eliott S., Lin, Chi-Yun, Zhang, Bo, Sil, Debangsu, Schaperdoth, Irene, Saryazdi, Setareh, Grossman, Robert B., Krebs, Carsten, and Bollinger, Jr., J. Martin
- Published
- 2024
- Full Text
- View/download PDF
6. The lowly chalazion
- Author
-
Kim, Eliott S., primary, Afshin, Evan E., additional, and Elahi, Ebby, additional
- Published
- 2022
- Full Text
- View/download PDF
7. The Lowly Chalazion
- Author
-
Eliott S. Kim, Evan E. Afshin, and Ebby Elahi
- Subjects
Ophthalmology - Abstract
Chalazia are localized cysts of chronic lipogranulomatous inflammation arising from the obstruction of sebaceous glands of the eyelid tarsal plate, including the Meibomian gland (deep chalazion) or Zeis gland (superficial chalazion). This disease entity is differentiated from the hordeolum (stye), an acute purulent localized swelling of the eyelid often associated with an eyelash follicle, Zeis gland, or Moll gland obstruction and infection. Ambiguously, the chalazion, hordeolum, and blepharitis are commonly categorized and described on a continuum in the literature [1]. While it is one of the most common eyelid disorders across all age demographics, the chalazion remains largely understudied and pathophysiological, epidemiological, and therapeutic findings exist fragmented in the literature. We discuss current understandings of the chalazion and provide current best practice guidelines supported by clinical anecdotal evidence.
- Published
- 2022
8. Progress Toward Understanding Protein Control of Reaction Outcome in the Diverse Reactivity of Iron(II)‐ and 2‐Oxoglutarate‐dependent Oxygenases
- Author
-
J. M. Bollinger, Carsten Krebs, Amie K. Boal, Alexey Silakov, John C. Price, Megan L. Matthews, Wei‐chen Chang, Ryan J. Martinie, Juan Pan, Noah P. Dunham, Eliott S. Wenger, Rachelle A. Copeland, and Chi‐Yun Lin
- Subjects
Genetics ,Molecular Biology ,Biochemistry ,Biotechnology - Published
- 2022
9. Progress Toward Understanding Protein Control of Reaction Outcome in the Diverse Reactivity of Iron(II)‐ and 2‐Oxoglutarate‐dependent Oxygenases
- Author
-
Bollinger, J. M., primary, Krebs, Carsten, additional, Boal, Amie K., additional, Silakov, Alexey, additional, Price, John C., additional, Matthews, Megan L., additional, Chang, Wei‐chen, additional, Martinie, Ryan J., additional, Pan, Juan, additional, Dunham, Noah P., additional, Wenger, Eliott S., additional, Copeland, Rachelle A., additional, and Lin, Chi‐Yun, additional
- Published
- 2022
- Full Text
- View/download PDF
10. Synthesis of 6,6‐ and 7,7‐difluoro‐1‐acetamidopyrrolizidines and their oxidation catalyzed by the nonheme Fe oxygenase LolO
- Author
-
Panth, Nabin, primary, Wenger, Eliott S., additional, Krebs, Carsten, additional, Bollinger, J. Martin, additional, and Grossman, Robert B., additional
- Published
- 2022
- Full Text
- View/download PDF
11. New York
- Author
-
Fields, Craig B. and Frank, Eliott S.
- Published
- 1998
12. A survey to evaluate research capacity and culture in an Australian University Hospital critical care program.
- Author
-
Shepherd K., Green M., Dwivedi D., Wang A., Hart N., Fenech K., Bulfin L., Eliott S., Ernest D., Lavrans K., Dinh L., Shehabi Y., Shepherd K., Green M., Dwivedi D., Wang A., Hart N., Fenech K., Bulfin L., Eliott S., Ernest D., Lavrans K., Dinh L., and Shehabi Y.
- Abstract
Background: A strong critical care research culture requires a vision, values and beliefs that advance critical care research practices, which bring substantial value and enhanced reputation for healthcare institutions. Organisational, team and individual level domains are fundamental to developing research capacity and culture. A positive research culture provides a platform to constantly challenge conventional medicine. Objective(s): To evaluate research capacity and culture using a validated survey instrument across three domains; organizational, team and individual levels of a critical care (Intensive Care Unit (ICU) and Peri-Operative Medicine) program to enable identification of areas for potential improvement. Method(s): A validated surveyi of research capacity and culture was distributed to critical care medical, nursing and allied health staff of a Victorian, tertiary hospital, across two campuses, in May 2017. Result(s): Surveys were received from 150 critical care staff (ICU [80] and perioperative [68]), 55 medical, 81 nursing and 6 allied health staff with 8 undeclared. Of surveyed staff, 31% were unsure about the research supports available at an organizational level, including funding, equipment and software. At both an organizational and a team perspective, perioperative staff reported significantly less support to conduct research than the ICU respondents. At an individual level, 55% of respondents were not currently involved in research activities and 5 % of respondents were involved in presenting research findings via conference or publication. The largest research barriers included lack of dedicated time for research 54%, followed by lack of research skills 33%. Career advancement 40% and skill development 42% were listed key as motivators to undertake research. Conclusion(s): Evaluating research culture and capacity of an organization, team and individual, facilitates the development of strategies for research capacity building, impacting on orga
- Published
- 2020
13. Evidence for Modulation of Oxygen-Rebound Rate in Control of Outcome by Iron(II)- and 2-Oxoglutarate-Dependent Oxygenases
- Author
-
Robert B. Grossman, Amelia J. Kim, Juan Pan, Minakshi Bhardwaj, Megan L. Matthews, J. Martin Bollinger, Benjamin D. Allen, Carsten Krebs, Eliott S. Wenger, and Christopher J. Pollock
- Subjects
Oxygenase ,Stereochemistry ,chemistry.chemical_element ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Oxygen ,Catalysis ,Article ,Hydroxylation ,chemistry.chemical_compound ,Colloid and Surface Chemistry ,Ferrous Compounds ,Bifunctional ,Molecular Structure ,Substrate (chemistry) ,Halogenation ,Stereoisomerism ,General Chemistry ,Ligand (biochemistry) ,0104 chemical sciences ,chemistry ,Oxygenases ,Ketoglutaric Acids ,Norvaline - Abstract
Iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenases generate iron(IV)-oxo (ferryl) intermediates that can abstract hydrogen from aliphatic carbons (R–H). Hydroxylation proceeds by coupling of the resultant substrate radical (R•) and oxygen of the Fe(III)–OH complex (“oxygen rebound”). Non-hydroxylation outcomes result from different fates of the Fe(III)–OH/R• state; for example, halogenation results from R• coupling to a halogen ligand cis to the hydroxide. We previously suggested that halogenases control substrate-cofactor disposition to disfavor oxygen rebound and permit halogen coupling to prevail. Here, we explored the general implication that, when a ferryl intermediate can ambiguously target two substrate carbons for different outcomes, rebound to the site capable of the alternative outcome should be slower than to the adjacent, solely hydroxylated site. We evaluated this prediction for (i) the halogenase SyrB2, which exclusively hydroxylates C5 of norvaline appended to its carrier protein but can either chlorinate or hydroxylate C4 and (ii) two bifunctional enzymes that normally hydroxylate one carbon before coupling that oxygen to a second carbon (producing an oxacycle) but can, upon encountering deuterium at the first site, hydroxylate the second site instead. In all three cases, substrate hydroxylation incorporates a greater fraction of solvent-derived oxygen at the site that can also undergo the alternative outcome than at the other site, most likely reflecting increased exchange of the initially O(2)-derived oxygen ligand in the longer-lived Fe(III)–OH/R• states. Suppression of rebound may thus be generally important for non-hydroxylation outcomes by these enzymes.
- Published
- 2019
14. Comorbidities, complications, and coding bias: does the number of diagnosis codes matter in predicting in-hospital mortality?
- Author
-
Iezzoni, Lisa I., Foley, Susan M., Daley, Jennifer, Hughes, John, Fisher, Eliott S., and Heeren, Timothy
- Subjects
Hospital records -- Evaluation ,Hospital patients -- Identification and classification ,Diagnosis -- Reports ,Databases -- Design and construction - Abstract
Physicians incompletely record the secondary diagnoses and accompanying illnesses (comorbidities) of hospital patients. Among 162,790 patients 65 years or older who were admitted to California hospitals for a stroke, pneumonia, a heart attack or congestive heart failure, the average number of diagnoses recorded was 5.5 on hospital discharge forms that can hold 25 diagnostic codes. Patients with secondary diagnoses such as cardiac arrest, irregular heart beat, congestive heart failure, pneumonia and respiratory failure had a higher risk of dying in the hospital. Patients with secondary diagnoses of diabetes, hypertension, previous heart attack, chest pain and premature heart beats had a lower risk of dying in the hospital. These conditions normally would be expected to increase the risk of death, but are considered inappropriate comorbidities to certain conditions by Medicare. Physicians may record more secondary diagnoses in the medical records of patients who die than in those of patients who survive. Increasing the number of fields on discharge forms may not ensure more complete medical records.
- Published
- 1992
15. Evidence for Modulation of Oxygen Rebound Rate in Control of Outcome by Iron(II)- and 2-Oxoglutarate-Dependent Oxygenases
- Author
-
Pan, Juan, primary, Wenger, Eliott S., additional, Matthews, Megan L., additional, Pollock, Christopher J., additional, Bhardwaj, Minakshi, additional, Kim, Amelia J., additional, Allen, Benjamin D., additional, Grossman, Robert B., additional, Krebs, Carsten, additional, and Bollinger, J. Martin, additional
- Published
- 2019
- Full Text
- View/download PDF
16. Free the 'Free Rivers' doctrine.
- Author
-
Frankel, Paul H., Fields, Craig B., and Frank, Eliott S.
- Subjects
Inland water transportation -- Taxation -- Cases ,Excise tax -- Cases ,Hartley Marine Corp. v. Paige (117 S. Ct. 942 (1997)) ,Company legal issue - Abstract
Looking back over the past year, one a the more upsetting actions of the Supreme Court of the United States was its refusal to review a decision of the West [...]
- Published
- 1998
17. Sedation intensity in the first 48 hours of mechanical ventilation and 180-day mortality: A multinational prospective longitudinal cohort study.
- Author
-
Weisbrodt L., Shehabi Y., Chamberlain J., Bicknell A., Roberts B., Casey E., Cheng A., Inskip D., Myburgh J., Holmes J., Santamaria J., Smith R., Nair P., Reynolds C., Johnson B., Sterba M., Wong K.K., Venugopal S., Rai V., Shahnaz M., Ramoo V., Jose S., Ozturk O., Ramlee S.N.Z., Foon B.S., Amran R., Narula R.K.A., Md Ramly E.S., Hapiz K.A., I-Liang L., Morad M.H.C., Ali M.N., Raihan H.N., Azizum S.I., Suzana Y., Haryati H., Zawati S.S., Ismeev J.N., Zulkarnain M.A., Omar M., Omar S.A., Ismail S.R., Hassan N., Zakaria Z., Mohtar S., Ahmad M., Suai W., Ai Li W., Lan J.S., Rohayah S.S., Mahadir F., Lian T.S., Zain M.M., Ahmad N., Mahazir K., Bakar A.A., Nan H.W., Tan Ai Ping S., Ngan S.C.L., Har L.C., Hassan J., Brown J., Gilders E., Parke R., McArthur C., Newby L., Simmonds C., Henderson S., Mehrtens J., Browne T., Cubis D., Goodson J., Nelson S., MacKle D., Pecher S., Ti L., Lim D., Wong Y., Ho B., Chia N., Yi N., Kalyanasundaram G., Webb S., Bellomo R., Kadiman S., Ti L.K., Howe B., Reade M.C., Khoo T.M., Alias A., Wong Y.-L., Mukhopadhyay A., Webb S.A., Green M., Bailey M.J., Ibrom E., Maher C., Mashonganyika C., McKee H., Bennett V., Cooper D.J., Vallance S., Eastwood G., Peck L., Reade M., Young H., Eliott S., Mercer I., Sidhu J., Whitfield A., Ding G., Hatfield P., Smith K., Coles T., Dennett J., Summers T., Ruther A., Anderson R., Jones E., Milliss D., Wong H., Botha J., Allsop S., Kanhere M., Wood J., Hogan C., Tai J., Williams T., Buckley A., Garrett P., McDonald S., Cuzner C., Seppelt I., Bass F., Edhouse P., Sana M., Weisbrodt L., Shehabi Y., Chamberlain J., Bicknell A., Roberts B., Casey E., Cheng A., Inskip D., Myburgh J., Holmes J., Santamaria J., Smith R., Nair P., Reynolds C., Johnson B., Sterba M., Wong K.K., Venugopal S., Rai V., Shahnaz M., Ramoo V., Jose S., Ozturk O., Ramlee S.N.Z., Foon B.S., Amran R., Narula R.K.A., Md Ramly E.S., Hapiz K.A., I-Liang L., Morad M.H.C., Ali M.N., Raihan H.N., Azizum S.I., Suzana Y., Haryati H., Zawati S.S., Ismeev J.N., Zulkarnain M.A., Omar M., Omar S.A., Ismail S.R., Hassan N., Zakaria Z., Mohtar S., Ahmad M., Suai W., Ai Li W., Lan J.S., Rohayah S.S., Mahadir F., Lian T.S., Zain M.M., Ahmad N., Mahazir K., Bakar A.A., Nan H.W., Tan Ai Ping S., Ngan S.C.L., Har L.C., Hassan J., Brown J., Gilders E., Parke R., McArthur C., Newby L., Simmonds C., Henderson S., Mehrtens J., Browne T., Cubis D., Goodson J., Nelson S., MacKle D., Pecher S., Ti L., Lim D., Wong Y., Ho B., Chia N., Yi N., Kalyanasundaram G., Webb S., Bellomo R., Kadiman S., Ti L.K., Howe B., Reade M.C., Khoo T.M., Alias A., Wong Y.-L., Mukhopadhyay A., Webb S.A., Green M., Bailey M.J., Ibrom E., Maher C., Mashonganyika C., McKee H., Bennett V., Cooper D.J., Vallance S., Eastwood G., Peck L., Reade M., Young H., Eliott S., Mercer I., Sidhu J., Whitfield A., Ding G., Hatfield P., Smith K., Coles T., Dennett J., Summers T., Ruther A., Anderson R., Jones E., Milliss D., Wong H., Botha J., Allsop S., Kanhere M., Wood J., Hogan C., Tai J., Williams T., Buckley A., Garrett P., McDonald S., Cuzner C., Seppelt I., Bass F., Edhouse P., and Sana M.
- Abstract
Objectives: In the absence of a universal definition of light or deep sedation, the level of sedation that conveys favorable outcomes is unknown. We quantified the relationship between escalating intensity of sedation in the first 48 hours of mechanical ventilation and 180-day survival, time to extubation, and delirium. Design(s): Harmonized data from prospective multicenter international longitudinal cohort studies Setting: Diverse mix of ICUs. Patient(s): Critically ill patients expected to be ventilated for longer than 24 hours. Intervention(s): Richmond Agitation Sedation Scale and pain were assessed every 4 hours. Delirium and mobilization were assessed daily using the Confusion Assessment Method of ICU and a standardized mobility assessment, respectively. Measurements and Main Results: Sedation intensity was assessed using a Sedation Index, calculated as the sum of negative Richmond Agitation Sedation Scale measurements divided by the total number of assessments. We used multivariable Cox proportional hazard models to adjust for relevant covariates. We performed subgroup and sensitivity analysis accounting for immortal time bias using the same variables within 120 and 168 hours. The main outcome was 180-day survival. We assessed 703 patients in 42 ICUs with a mean (sd) Acute Physiology and Chronic Health Evaluation II score of 22.2 (8.5) with 180-day mortality of 32.3% (227). The median (interquartile range) ventilation time was 4.54 days (2.47-8.43 d). Delirium occurred in 273 (38.8%) of patients. Sedation intensity, in an escalating dose-dependent relationship, independently predicted increased risk of death (hazard ratio [95% CI], 1.29 [1.15-1.46]; p < 0.001, delirium hazard ratio [95% CI], 1.25 [1.10-1.43]), p value equals to 0.001 and reduced chance of early extubation hazard ratio (95% CI) 0.80 (0.73-0.87), p value of less than 0.001. Agitation level independently predicted subsequent delirium hazard ratio [95% CI], of 1.25 (1.04-1.49), p value equals to
- Published
- 2018
18. Day or overnight transfusion in critically ill patients: does it matter?
- Author
-
Aubron, C., Kandane-Rathnayake, R., Andrianopoulos, N., Westbrook, A., Engelbrecht, S., Ozolins, I., Bailey, M., Murray, L., Cooper, D., Wood, E., McQuilten, Z., Pettilä, V., Nichol, A., Syres, G., Phillips, L., Street, A., French, C., Orford, N., Santamaria, J., Bellomo, R., Vallance, S., McArthur, C., McGuiness, S., Newby, L., Simmonds, C., Parke, R., Buhr, H., Goldsmith, D., O'Sullivan, K., Mercer, I., Gazzard, R., Tauschke, C., Hill, D., Fletcher, J., Boschert, C., Koch, G., Ernest, D., Eliott, S., Howe, B., Hawker, F., Ellem, K., Duff, K., Henderson, S., Mehrtens, J., Milliss, D., Wong, H., Arora, S., O'Bree, B., Shepherd, K., Ihle, B., Ho, S., Graan, M., Bernsten, A., Ryan, E., Botha, J., Vuat, J., Kinmonth, A., Fraser, M., Richards, B., Tallott, M., Whitbread, R., Freebairn, R., Thomas, L., Parr, M., Micallef, S., Deshpande, K., Wood, J., Williams, Teresa, Tai, J., Boase, A., Galt, P., King, B., Price, R., Tomlinson, J., Cole, L., Seppelt, I., Weisbrodt, L., Gresham, R., Nikas, M., Laing, J., Bell, J., McHugh, G., Hancock, D., Kirkham, S., Shehabi, Y., Campbell, M., Aubron, C., Kandane-Rathnayake, R., Andrianopoulos, N., Westbrook, A., Engelbrecht, S., Ozolins, I., Bailey, M., Murray, L., Cooper, D., Wood, E., McQuilten, Z., Pettilä, V., Nichol, A., Syres, G., Phillips, L., Street, A., French, C., Orford, N., Santamaria, J., Bellomo, R., Vallance, S., McArthur, C., McGuiness, S., Newby, L., Simmonds, C., Parke, R., Buhr, H., Goldsmith, D., O'Sullivan, K., Mercer, I., Gazzard, R., Tauschke, C., Hill, D., Fletcher, J., Boschert, C., Koch, G., Ernest, D., Eliott, S., Howe, B., Hawker, F., Ellem, K., Duff, K., Henderson, S., Mehrtens, J., Milliss, D., Wong, H., Arora, S., O'Bree, B., Shepherd, K., Ihle, B., Ho, S., Graan, M., Bernsten, A., Ryan, E., Botha, J., Vuat, J., Kinmonth, A., Fraser, M., Richards, B., Tallott, M., Whitbread, R., Freebairn, R., Thomas, L., Parr, M., Micallef, S., Deshpande, K., Wood, J., Williams, Teresa, Tai, J., Boase, A., Galt, P., King, B., Price, R., Tomlinson, J., Cole, L., Seppelt, I., Weisbrodt, L., Gresham, R., Nikas, M., Laing, J., Bell, J., McHugh, G., Hancock, D., Kirkham, S., Shehabi, Y., and Campbell, M.
- Abstract
Background and objectives: The timing of blood administration in critically ill patients is first driven by patients' needs. This study aimed to define the epidemiology and significance of overnight transfusion in critically ill patients. Materials and methods: This is a post hoc analysis of a prospective multicentre observational study including 874 critically ill patients receiving red blood cells, platelets, fresh frozen plasma (FFP) or cryoprecipitate. Characteristics of patients receiving blood only during the day (8 am up until 8 pm) were compared to those receiving blood only overnight (8 pm up until 8 am). Characteristics of transfusion were compared, and factors independently associated with major bleeding were analysed. Results: The 287 patients transfused during the day only had similar severity and mortality to the 258 receiving blood products overnight only. Although bleeding-related admission diagnoses were similar, major bleeding was the indication for transfusion in 12% of patients transfused in daytime only versus 30% of patients transfused at night only (P < 0·001). Similar total amount of blood products were transfused at day and night (2856 versus 2927); however, patients were more likely to receive FFP and cryoprecipitate at night compared with daytime. Overnight transfusion was independently associated with increased odds of major bleeding (odds ratio, 3·16, 95% confidence interval, 2·00–5·01). Conclusion: Transfusion occurs evenly across day and night in ICU; nonetheless, there are differences in type of blood products administered that reflect differences in indication. Critically ill patients were more likely to receive blood for major bleeding at night irrespective of admission diagnosis.
- Published
- 2018
19. Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliability.
- Author
-
Bell S., Green C., Howard-Griffin R., Inskip D., Litton E., MacIsaac C., McCairn A., Ridgeon E., Bellomo R., Myburgh J., Saxena M., Weatherall M., Jahan R., Arawwawala D., Butt W., Camsooksai J., Carle C., Mahambrey T., Moondi P., Newby L., O'Connor S., Pegg C., Pope A., Reschreiter H., Richards B., Robertson M., Rodgers H., Shehabi Y., Smith I., Smith J., Smith N., Tilsley A., Whitehead C., Willett E., Wong K., Woodford C., Wright S., Young P., Cheng A., Cirstea E., Cohen J., Cranshaw J., Delaney A., Eastwood G., Eliott S., Franke U., Gantner D., Bell S., Green C., Howard-Griffin R., Inskip D., Litton E., MacIsaac C., McCairn A., Ridgeon E., Bellomo R., Myburgh J., Saxena M., Weatherall M., Jahan R., Arawwawala D., Butt W., Camsooksai J., Carle C., Mahambrey T., Moondi P., Newby L., O'Connor S., Pegg C., Pope A., Reschreiter H., Richards B., Robertson M., Rodgers H., Shehabi Y., Smith I., Smith J., Smith N., Tilsley A., Whitehead C., Willett E., Wong K., Woodford C., Wright S., Young P., Cheng A., Cirstea E., Cohen J., Cranshaw J., Delaney A., Eastwood G., Eliott S., Franke U., and Gantner D.
- Abstract
OBJECTIVE: Trials in critical care have previously used unvalidated systems to classify cause of death. We aimed to provide initial validation of a method to classify cause of death in intensive care unit patients. DESIGN, SETTING AND PARTICIPANTS: One hundred case scenarios of patients who died in an ICU were presented online to raters, who were asked to select a proximate and an underlying cause of death for each, using the ICU Deaths Classification and Reason (ICU-DECLARE) system. We evaluated two methods of categorising proximate cause of death (designated Lists A and B) and one method of categorising underlying cause of death. Raters were ICU specialists and research coordinators from Australia, New Zealand and the United Kingdom. MAIN OUTCOME MEASURES: Inter-rater reliability, as measured by the Fleiss multirater kappa, and the median proportion of raters choosing the most likely diagnosis (defined as the most popular classification choice in each case). RESULTS: Across all raters and cases, for proximate cause of death List A, kappa was 0.54 (95% CI, 0.49-0.60), and for proximate cause of death List B, kappa was 0.58 (95% CI, 0.53-0.63). For the underlying cause of death, kappa was 0.48 (95% CI, 0.44-0.53). The median proportion of raters choosing the most likely diagnosis for proximate cause of death, List A, was 77.5% (interquartile range [IQR], 60.0%-93.8%), and the median proportion choosing the most likely diagnosis for proximate cause of death, List B, was 82.5% (IQR, 60.0%-92.5%). The median proportion choosing the most likely diagnosis for underlying cause was 65.0% (IQR, 50.0%-81.3%). Kappa and median agreement were similar between countries. ICU specialists showed higher kappa and median agreement than research coordinators. CONCLUSIONS: The ICU-DECLARE system allowed ICU doctors to classify the proximate cause of death of patients who died in the ICU with substantial reliability.
- Published
- 2016
20. Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial).
- Author
-
Stub D., Conquest A., Archer J.S., Bernard S., Hart G.K., Bellomo R., Eastwood G.M., Schneider A.G., Suzuki S., Peck L., Young H., Tanaka A., Martensson J., Warrillow S., McGuinness S., Parke R., Gilder E., Mccarthy L., Galt P., Taori G., Eliott S., Lamac T., Bailey M., Harley N., Barge D., Hodgson C.L., Morganti-Kossmann M.C., Pebay A., Stub D., Conquest A., Archer J.S., Bernard S., Hart G.K., Bellomo R., Eastwood G.M., Schneider A.G., Suzuki S., Peck L., Young H., Tanaka A., Martensson J., Warrillow S., McGuinness S., Parke R., Gilder E., Mccarthy L., Galt P., Taori G., Eliott S., Lamac T., Bailey M., Harley N., Barge D., Hodgson C.L., Morganti-Kossmann M.C., and Pebay A.
- Abstract
Background: In intensive care observational studies, hypercapnia after cardiac arrest (CA) is independently associated with improved neurological outcome. However, the safety and feasibility of delivering targeted therapeutic mild hypercapnia (TTMH) for such patients is untested. Method(s): In a phase II safety and feasibility multi-centre, randomised controlled trial, we allocated ICU patients after CA to 24 h of targeted normocapnia (TN) (PaCO2 35-45 mmHg) or TTMH (PaCO2 50-55 mmHg). The primary outcome was serum neuron specific enolase (NSE) and S100b protein concentrations over the first 72 h assessed in the first 50 patients surviving to day three. Secondary end-points included global measure of function assessment at six months and mortality for all patients. Result(s): We enrolled 86 patients. Their median age was 61 years (58, 64 years) and 66 (79%) were male. Of these, 50 patients (58%) survived to day three for full biomarker assessment. NSE concentrations increased in the TTMH group (p = 0.02) and TN group (p = 0.005) over time, with the increase being significantly more pronounced in the TN group (p(interaction)=0.04). S100b concentrations decreased over time in the TTMH group (p < 0.001) but not in the TN group (p = 0.68). However, the S100b change over time did not differ between the groups (p(interaction)=0.23). At six months, 23 (59%) TTMH patients had good functional recovery compared with 18 (46%) TN patients. Hospital mortality occurred in 11 (26%) TTMH patients and 15 (37%) TN patients (p = 0.31). Conclusion(s): In CA patients admitted to the ICU, TTMH was feasible, appeared safe and attenuated the release of NSE compared with TN. These findings justify further investigation of this novel treatment.Copyright © 2016.
- Published
- 2016
21. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study
- Author
-
Seppelt, I, Sullivan, E, Bellomo, R, Ellwood, D, Finfer, S, Howe, B, Knight, M, McArthur, C, McDonnell, N, McLintock, C, Morgan, TJ, Morrison, S, Nguyen, N, Peek, MJ, Pollock, W, Vaughan, G, Wang, YA, Web, SAR, Pettila, V, Bailey, M, Cooper, DJ, Cretikos, M, Davies, AR, Harrigan, PWJ, Hart, GK, Iredell, J, Mitchell, I, Nichol, A, Paterson, DL, Peake, S, Richards, B, Stephens, D, Turner, A, Yung, M, Homer, C, Pulver, LJ, Elliot, E, Ho, T, Thompson, J, Zurynski, Y, Callaway, L, Welsh, A, Oats, J, Gupta, B, Hague, W, McKee, A, McGuinness, S, Parke, R, Whitley, A, Newby, L, Simmonds, C, Eastwood, G, Peck, L, Fletcher, J, Boschert, C, Smith, J, Bennett, G, Ong, L, Nand, K, Reece, G, Sara, T, Ernest, D, Eliott, S, Sidhu, J, Carroll, A, Richmond, S, Wenck, D, Bishop, G, Ashley, R, Crowfoot, E, Henderson, S, Mehrtens, J, Fizzell, J, Faithfull, S, Baynes, T, Bersten, A, Ryan, E, Scroggs, S, Blythe, D, Palermo, A, Bortz, P, Lodding, K, Mott, M, Vagg, S, Frengley, R, Haslam, A, La Pine, M, Bingham, T, Cavill, D, Jennings, B, Parr, M, Micallef, S, Chaplin, J, Gregory, K, Presneill, J, Sutton, J, Horsley, C, Tai, J, Tilsley, A, Crozier, T, Galt, P, Reilly, M, Rockell, J, Hoyling, L, Weisbrodt, L, Bell, J, Flanagan, A, Laing, J, Duke, G, Parkes, M, Carr, J, Lambert, J, Boots, R, Lassig-Smith, M, McLaine, J, Thomas, J, Winter, S, Barge, D, Caf, T, Harley, N, MacIsaac, C, Bird, S, Raper, R, Chamberlain, J, Gould, A, McEntaggart, G, Gattas, D, Rajbhandari, D, Rees, C, Baker, S, Bicknell, A, Roberts, B, Nair, P, Reynolds, C, Evans, J, Gordon, G, Jones, L, Radtke, S, Andrews, L, Elder, R, Hicks, P, Mackle, D, Boyd, R, Mudaliar, Y, Nayyar, V, Skelly, C, Stachowski, E, Sterba, M, Johnson, B, and Robinson, J
- Subjects
Adult ,Critical Care ,Adolescent ,Critical Illness ,Pregnancy Outcome ,Australia ,Prenatal Care ,Cohort Studies ,Young Adult ,Influenza A Virus, H1N1 Subtype ,Risk Factors ,Pregnancy ,General & Internal Medicine ,Influenza, Human ,Humans ,Female ,Pregnancy Complications, Infectious ,New Zealand - Published
- 2010
22. Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial.
- Author
-
Hebert P., Murphy E., Foxall J., Skrobik Y., Harvey J., Chitu S., Sirois C., Nadon C., Dolle S., Barge D., Caf T., Howe B., Bellomo R., Eastwood G., Peck L., Goldsmith D., O'Sullivan K., Ernest D., Radford S., Whitfield A., Cross A., Eliott S., Sidhu J., Mercer I., Hamilton A., Botha J., Vuat J., Allsop S., Fowler N., Crozier T., Barrett J., Wright C., Galt P., Culhane C., Ioannidis R., Burton S., Reily M., Weeraratna C., Seppelt I., Weisbrodt L., Bond R., Evans D., Rivett J., O'Connor S., Poole A., Woolfe C., Rajbhandari D., Rees C., Edington J., Fletcher J., Smith J., Boschert C., Reece G., Sara T., Nand K., Bersten A., Gallus A., Matheson E., O'Callaghan M., Orford N., Elderkin T., Fraser M., Bone A., Salerno T., Kinmonth A., Arora S., O'Bree B., Shepherd K., Davey-Quinn A., Sterba M., Johnson B.R., Xu R., Hill F., Ramadoss R., Wood J., Crowther M., Cook D., Guyatt G., Zytaruk N., McDonald E., Williamson D., Albert M., Dodek P., Finfer S., Vallance S., Heels-Ansdell D., McIntyre L., Mehta S., Lamontagne F., Muscedere J., Jacka M., Lesur O., Kutsiogiannis J., Friedrich J., Klinger J.R., Qushmaq I., Burry L., Khwaja K., Sheppard J.-A., Warkentin T.E., Tkaczyk A., Clarke F., Hall R., Rocker G., Julien L., Wright D., Roy C., Theriault J., Pleasance S., Meade M., Hand L., Freitag A., Wynne C., Duffett M., Kho M., Granton J., Matte A., Farias P., Chu L., Brockest N., Go S., McGrath-Chong M., Dennis M., Lipkus M., Stern E., Albert R., Langevin S., Lauzier F., Turgeon A.F., Blais M., Beauparlant M., Asselin J., Gagne C., Thibodeau M., Poirier G., Neas I., Spearson S., Watpool I., McArdle T., Gaudert C., Marchand P., Davidson C., Pagliarello J., Lewis M.-J., Gosselin A.-A., Deroy P., Ethier C., Tirgari S., Steinberg L., McDonald R., Sivanantham V., Bandayrel K., Quittnat-Pelletier F., Kramer-Kile M., Brown M., Kim S., Fowler R., Marinoff N., Code K., Bojilov B., Parsotam D., Marshall J., Smith O., Fry B., Porretta K., Lee Y., Morrissey J., Wen V., Fleury S., Godfrey N., Hammond S., Mann E., Myers M., Robinson A., Keenan S., Reynolds S., Svetik M., Osch M.V., Chittock D., Dhingra V., Gardner M., Logie S., Foster D., Autio R., Davies D., Ganz P., Smith L., Ashley B.J., Mans S., Doig C., Knox L., Wilson C., Champagne K., Ferguson N., Stevenson J., Elman J., Kutsogiannis J., Thompson P., Whalen N., Lellouche F., Ferland M.-C., Dussault P., Jacob C., Morneau M.-E., Laberge N., Karachi T., Irwin M., Chan C., Sonnema L., Marsh K., Maurer J., Kreidl T., Varden C., Kinjerski C., Banici L., Havell L., Wood G., Auld F., Atkins L., Proulx S., Hollinger G., Shende V., Belcastro V., Plaxton B., Foss A., Paunovic B., Wiebe K., Marten N., Eisenstat J., Doerle T., Sharpe M., Madady M., Cooper J., Davies A., Weatherburn C., Board J., Bennett V., Ramakrishnan N., Bird S., Potter J., O'Connor A., Ankers S., Cade J., Hebert P., Murphy E., Foxall J., Skrobik Y., Harvey J., Chitu S., Sirois C., Nadon C., Dolle S., Barge D., Caf T., Howe B., Bellomo R., Eastwood G., Peck L., Goldsmith D., O'Sullivan K., Ernest D., Radford S., Whitfield A., Cross A., Eliott S., Sidhu J., Mercer I., Hamilton A., Botha J., Vuat J., Allsop S., Fowler N., Crozier T., Barrett J., Wright C., Galt P., Culhane C., Ioannidis R., Burton S., Reily M., Weeraratna C., Seppelt I., Weisbrodt L., Bond R., Evans D., Rivett J., O'Connor S., Poole A., Woolfe C., Rajbhandari D., Rees C., Edington J., Fletcher J., Smith J., Boschert C., Reece G., Sara T., Nand K., Bersten A., Gallus A., Matheson E., O'Callaghan M., Orford N., Elderkin T., Fraser M., Bone A., Salerno T., Kinmonth A., Arora S., O'Bree B., Shepherd K., Davey-Quinn A., Sterba M., Johnson B.R., Xu R., Hill F., Ramadoss R., Wood J., Crowther M., Cook D., Guyatt G., Zytaruk N., McDonald E., Williamson D., Albert M., Dodek P., Finfer S., Vallance S., Heels-Ansdell D., McIntyre L., Mehta S., Lamontagne F., Muscedere J., Jacka M., Lesur O., Kutsiogiannis J., Friedrich J., Klinger J.R., Qushmaq I., Burry L., Khwaja K., Sheppard J.-A., Warkentin T.E., Tkaczyk A., Clarke F., Hall R., Rocker G., Julien L., Wright D., Roy C., Theriault J., Pleasance S., Meade M., Hand L., Freitag A., Wynne C., Duffett M., Kho M., Granton J., Matte A., Farias P., Chu L., Brockest N., Go S., McGrath-Chong M., Dennis M., Lipkus M., Stern E., Albert R., Langevin S., Lauzier F., Turgeon A.F., Blais M., Beauparlant M., Asselin J., Gagne C., Thibodeau M., Poirier G., Neas I., Spearson S., Watpool I., McArdle T., Gaudert C., Marchand P., Davidson C., Pagliarello J., Lewis M.-J., Gosselin A.-A., Deroy P., Ethier C., Tirgari S., Steinberg L., McDonald R., Sivanantham V., Bandayrel K., Quittnat-Pelletier F., Kramer-Kile M., Brown M., Kim S., Fowler R., Marinoff N., Code K., Bojilov B., Parsotam D., Marshall J., Smith O., Fry B., Porretta K., Lee Y., Morrissey J., Wen V., Fleury S., Godfrey N., Hammond S., Mann E., Myers M., Robinson A., Keenan S., Reynolds S., Svetik M., Osch M.V., Chittock D., Dhingra V., Gardner M., Logie S., Foster D., Autio R., Davies D., Ganz P., Smith L., Ashley B.J., Mans S., Doig C., Knox L., Wilson C., Champagne K., Ferguson N., Stevenson J., Elman J., Kutsogiannis J., Thompson P., Whalen N., Lellouche F., Ferland M.-C., Dussault P., Jacob C., Morneau M.-E., Laberge N., Karachi T., Irwin M., Chan C., Sonnema L., Marsh K., Maurer J., Kreidl T., Varden C., Kinjerski C., Banici L., Havell L., Wood G., Auld F., Atkins L., Proulx S., Hollinger G., Shende V., Belcastro V., Plaxton B., Foss A., Paunovic B., Wiebe K., Marten N., Eisenstat J., Doerle T., Sharpe M., Madady M., Cooper J., Davies A., Weatherburn C., Board J., Bennett V., Ramakrishnan N., Bird S., Potter J., O'Connor A., Ankers S., and Cade J.
- Abstract
Background: Thrombocytopenia occurs in 20% to 45% of critically ill medical-surgical patients. The 4Ts heparin-induced thrombocytopenia (HIT) score (with 4 domains: Thrombocytopenia, Timing of thrombocytopenia, Thrombosis and o. Ther reason[s] for thrombocytopenia) might reliably identify patients at low risk for HIT. Interobserver agreement on 4Ts scoring is uncertain in this setting. Objective(s): To evaluate whether a published clinical prediction rule (the "4Ts score") reliably rules out HIT in "low-risk" intensive care unit (ICU) patients as assessed by research coordinators (who prospectively scored) and 2 adjudicators (who scored retrospectively) during an international heparin thromboprophylaxis trial (PROTECT, NCT00182143). Method(s): Of 3746 medical-surgical ICU patients in PROTECT, 794 met the enrollment criteria for this HIT substudy. Enrollment was predicated on one of the following occurring in ICU: platelets less than 50 x 109/L, platelets decreased to 50% of ICU admission value (if admission value <100 x 109/L), any venous thrombosis, or if HIT was otherwise clinically suspected. Independently, 4Ts scores were completed in real time by research coordinators blinded to study drug and laboratory HIT results, and retrospectively by 2 adjudicators blinded to study drug, laboratory HIT results, and research coordinators' scores; the adjudicators arrived at consensus in all cases. Of the 763 patients, 474 had a central or local laboratory HIT test performed and had 4Ts scoring by adjudicators; 432 were scored by trained research coordinators. Heparin-induced thrombocytopenia was defined by a centrally performed positive serotonin release assay (SRA). Result(s): Of the 474 patients with central adjudication, 407 (85.9%) had a 4Ts score of 3 or lower, conferring a low pretest probability (PTP) of HIT; of these, 6 (1.5% [95% confidence interval, 0.7%-3.2%) had a positive SRA. Fifty-nine (12.4%) had a moderate PTP (4Ts score of 4-5); of these, 4 (6.8%) had a p
- Published
- 2014
23. A national survey of Australian Intensive Care Unit (ICU) Liaison Nurse (LN) services.
- Author
-
Ernest D., Chaboyer W., Doric A., Endacott R., Eliott S., Ernest D., Chaboyer W., Doric A., Endacott R., and Eliott S.
- Abstract
Background: The Intensive Care Unit (ICU) Liaison Nurses (LNs) emerged as a member of the multidisciplinary team to: assist in the transition of patients from ICU to the ward, respond to the deteriorating patient in an appropriate and timely manner, and in some instances act as an integral member of Rapid Response Teams (RRT). Purpose(s): To identify the common core aspects and diversity within the ICU LN role across Australia and to determine whether the ICU LN hours of operation and the participation in MET teams has any impact on the activities undertaken by the ICU LN. Method(s): This descriptive survey of 152 Australian ICUs was conducted in April 2010. The Advanced Practice Nurse (APN) framework was used to develop the survey instrument, which comprised of four scales, education (5 items), collaboration (6 items), practice (8 items) research and quality (6 items) and a number of demographic questions. Descriptive statistics (mean, standard deviation (SD), median, interquartile ranges (IQR) and frequency) were used to summarise the data. Student's t-tests and Pearson's correlations were used to test the hypotheses. Result(s): Surveys were received from 113 hospitals (55 metropolitan, 58 regional): a 74% response rate. ICU LN services operated in 31 (27%) of these hospitals. LN services tended to operate in larger hospitals with higher ICU admission rates. The median weekly hours of operation was 56 (IQR 30; range 7-157), delivered by a median of 1.4 (IQR 0.9; range 0.0-4.2) Full Time Equivalent (FTE) staff. The median weekly patient visits made by the LN was 25 (IQR 44; range 2-145). The LN was reported to be a member of the Medical Emergency Team (MET) in 17 (68%) of the 25 hospitals that provided both MET and ICU LN services. The ICU LN activities were grouped under four key Advanced Practice Nurse (APN) domains: education, collaboration, practice and research/quality. Mean scale scores were calculated for each APN domain. The ICU LN reported being involved i
- Published
- 2014
24. A national survey of Australian ICU liaison nurse services
- Author
-
Eliott, S., primary, Chaboyer, W., additional, Ernest, D., additional, Doric, A., additional, and Endacott, R., additional
- Published
- 2011
- Full Text
- View/download PDF
25. HEMODYNAMIC RESPONSES AND DISCRIMINATE ANALYSIS TO IDENTIFY INDIVIDUALS WITH ISCHEMIC ELECTROCARDIOGRAMS
- Author
-
Eliott, S. C., Hutchison, W. W., and Jeskev, D. R.
- Published
- 1985
26. Electronic Commerce: B2C Strategies and Models
- Author
-
Eliott, S, primary
- Published
- 2003
- Full Text
- View/download PDF
27. A pheromonal function for the crural glands of the onychophoranCephalofovea tomahmontis(Onychophora: Peripatopsidae)
- Author
-
Eliott, S., primary, Tait, N. N., additional, and Briscof, D. A., additional
- Published
- 1993
- Full Text
- View/download PDF
28. Patterns in Dictyostelium discoideum: the role of myosin II in the transition from the unicellular to the multicellular phase
- Author
-
Eliott, S., primary, Joss, G.H., additional, Spudich, A., additional, and Williams, K.L., additional
- Published
- 1993
- Full Text
- View/download PDF
29. The distribution of myosin II in Dictyostelium discoideum slug cells.
- Author
-
Eliott, S, primary, Vardy, P H, additional, and Williams, K L, additional
- Published
- 1991
- Full Text
- View/download PDF
30. An integrative review and meta-synthesis of the scope and impact of intensive care liaison and outreach services.
- Author
-
Endacott R, Eliott S, and Chaboyer W
- Subjects
- *
INTENSIVE care units , *PATIENTS , *HOSPITAL care , *NURSES , *MORTALITY - Abstract
Aim. To determine activities and outcomes of intensive care unit Liaison Nurse/Outreach services. The review comprised two stages: (1) integrative review of qualitative and quantitative studies examining intensive care liaison/outreach services in the UK and Australia and (2) meta-synthesis using the Nursing Role Effectiveness Model as an a priori model. Background. Acute ward patients are at risk of adverse events and patients recovering from critical illness are vulnerable to deterioration. Proactive and reactive strategies have been implemented to facilitate timely identification of patients at risk. Design. Systematic review. Methods. A range of data bases was searched from 2000--2008. Studies were eligible for review if they included adults in any setting where intensive care unit Liaison Nurse or Outreach services were provided. From 1423 citations and 65 abstracts, 20 studies met the inclusion criteria. Results. Intensive care liaison/outreach services had a beneficial impact on intensive care mortality, hospital mortality, unplanned intensive care admissions/re-admissions, discharge delay and rates of adverse events. A range of research methods were used; however, it was not possible to conclude unequivocally that the intensive care liaison/outreach service had resulted in improved outcomes. The major unmeasured benefit across all studies was improved communication pathways between critical care and ward staff. Outcomes for nurses in the form of improved confidence, knowledge and critical care skills were identified in qualitative studies but not measured. Conclusion. The varied nature of the intensive care liaison/outreach services reviewed in these studies suggests that they should be treated as bundled interventions, delivering a treatment package of care. Further studies should examine the impact of critical care support on the confidence and skills of ward nurses. Relevance to clinical practice. Advanced nursing roles can improve outcomes for patients who are vulnerable to deterioration. The Nursing Role Effectiveness Model provides a useful framework for evaluating the impact of these roles. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
31. Enteral nutrition in Australian and New Zealand intensive care units
- Author
-
Peake, Sandra L., Chapman, Marianne J., Davies, Andrew R., Moran, John L., Connor, Stephanie O., Emma Ridley, Patricia Williams, The George Institute for Global Health, Anzics, The Clinical Trials Group, Maher, C., Brom, E., Mashonganyika, C., Davies, A., Vallance, S., Bennett, V., Parke, R., Gilder, E., Brown, J., Mcarthur, C., Newby, L., Simmonds, C., Bellomo, R., Eastwood, G., Ernest, D., Eliott, S., Sidhu, J., Ellem, K., Meaks, S., Mitchell, I., Crawford, E., Ashley, R., Henderson, S., Mehrtens, J., Milliss, D., Wong, H., Vij, S., Bree, B. O., Shepherd, K., Verghese, S., Matheson, E., Waters, A., Cattington, C., Fraser, M., Elderkin, T., Richards, B., Tallott, M., Whitebread, R., Cameron, R., Hatter, S., Freebairn, R., Chadwick, L., Michael Parr, Micallef, S., Ramadoss, R., Wood, J., Deepak Bhonagiri, Williams, T., Tai, J., Tilsley, A., and Seppelt, I.
32. Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliability
- Author
-
Ridgeon E, Bellomo R, Myburgh J, Saxena M, Weatherall M, Jahan R, Arawwawala D, Bell S, Butt W, Camsooksai J, Coralie Carle, Cheng A, Cirstea E, Cohen J, Cranshaw J, Delaney A, Eastwood G, Eliott S, Franke U, and Young P
33. The impact of an ICU liaison nurse service on patient outcomes
- Author
-
Eliott, S. J., Ernest, D., Doric, A. G., Page, K. N., Worrall-Carter, L. J., Thalib, L., and Wendy Chaboyer
34. Rather than try an alternative to tenure, why not experiment within the existing system?
- Author
-
Elfner, Eliott S.
- Subjects
LETTERS to the editor ,TENURE of teachers - Abstract
A letter to the editor is presented in response to the article "Up or Out for the Tenure System?" by Richard Meyer in the October 14 issue.
- Published
- 1975
35. Global Change Newsletter
- Author
-
The International Geosphere–Biosphere Programme (IGBP), Eliott, S, and Bellamy, J
- Subjects
climate change ,ecology and environment - Abstract
The Global Change Open Science Conference – Amsterdam, July 2001. This edition of the Global Change Newsletter focuses on outcomes of the recent Open Science Conference, Challenges of a Changing Earth. The Newsletter begins with an introduction to the event and feedback from conference participants, Previously curated at: http://cedadocs.ceda.ac.uk/292/ The publish date on this item was its original published date. This item was previously associated with content (as an official url) at: http://www.igbp.kva.se. This item was part of the Global Change Newsletter series. This work was funded by: International Council for Science (ICSU). This item was not refereed before the publication Main files in this record: NL_47.pdf Item originally deposited with Centre for Environmental Data Analysis (CEDA) document repository by Ms Belinda Robinson. Transferred to CEDA document repository community on Zenodo on 2022-11-24
- Published
- 2001
- Full Text
- View/download PDF
36. Engineering Substrate Channeling in Assembly-Line Terpene Biosynthesis.
- Author
-
Wenger ES, Schultz K, Marmorstein R, and Christianson DW
- Abstract
Fusicoccadiene synthase from P. amygdala (PaFS) is a bifunctional assembly-line terpene synthase containing a prenyltransferase domain that generates geranylgeranyl diphosphate (GGPP) from dimethylallyl diphosphate (DMAPP) and three equivalents of isopentenyl diphosphate (IPP), and a cyclase domain that converts GGPP into fusicoccadiene, a precursor of the diterpene glycoside Fusicoccin A. The two catalytic domains are linked by a flexible 69-residue polypeptide segment. The prenyltransferase domain mediates oligomerization to form predominantly octamers, and cyclase domains are randomly splayed out around the prenyltransferase core. Previous studies suggest that substrate channeling is operative in catalysis, since most of the GGPP formed by the prenyltransferase remains on the protein for the cyclization reaction. Here, we demonstrate that the flexible linker is not required for substrate channeling, nor must the prenyltransferase and cyclase domains be covalently linked to sustain substrate channeling. Moreover, substrate competition experiments with other diterpene cyclases indicate that the PaFS prenyltransferase and cyclase domains are preferential partners regardless of whether they are covalently linked or not. The cryo-EM structure of engineered "linkerless" construct PaFS
LL , in which the 69-residue linker is spliced out and replaced with the tripeptide PTQ, reveals that cyclase pairs associate with all four sides of the prenyltransferase octamer. Taken together, these results suggest that optimal substrate channeling is achieved when a cyclase domain associates with the side of the prenyltransferase octamer, regardless of whether the two domains are covalently linked and regardless of whether this interaction is transient or locked in place., Competing Interests: Competing Interests The authors declare no competing interests.- Published
- 2024
- Full Text
- View/download PDF
37. Methods for the preparation and analysis of the diterpene cyclase fusicoccadiene synthase.
- Author
-
Wenger ES and Christianson DW
- Subjects
- Dimethylallyltranstransferase metabolism, Dimethylallyltranstransferase chemistry, Dimethylallyltranstransferase genetics, Diterpenes metabolism, Diterpenes chemistry, Enzyme Assays methods, Polyisoprenyl Phosphates metabolism, Polyisoprenyl Phosphates chemistry, Cyclization, Alkyl and Aryl Transferases metabolism, Alkyl and Aryl Transferases chemistry, Alkyl and Aryl Transferases genetics
- Abstract
Prenyltransferases are terpene synthases that combine 5-carbon precursor molecules into linear isoprenoids of varying length that serve as substrates for terpene cyclases, enzymes that catalyze fascinating cyclization reactions to form diverse terpene natural products. Terpenes and their derivatives comprise the largest class of natural products and have myriad functions in nature and diverse commercial uses. An emerging class of bifunctional terpene synthases contains both prenyltransferase and cyclase domains connected by a disordered linker in a single polypeptide chain. Fusicoccadiene synthase from Phomopsis amygdali (PaFS) is one of the most well-characterized members of this subclass and serves as a model system for the exploration of structure-function relationships. PaFS has been structurally characterized using a variety of biophysical techniques. The enzyme oligomerizes to form a stable core of six or eight prenyltransferase domains that produce a 20-carbon linear isoprenoid, geranylgeranyl diphosphate (GGPP), which then transits to the cyclase domains for the generation of fusicoccadiene. Cyclase domains are in dynamic equilibrium between randomly splayed-out and prenyltransferase-associated positions; cluster channeling is implicated for GGPP transit from the prenyltransferase core to the cyclase domains. In this chapter, we outline the methods we are developing to interrogate the nature of cluster channeling in PaFS, including enzyme activity and product analysis assays, approaches for engineering the linker segment connecting the prenyltransferase and cyclase domains, and structural analysis by cryo-EM., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
38. Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial).
- Author
-
Eastwood GM, Schneider AG, Suzuki S, Peck L, Young H, Tanaka A, Mårtensson J, Warrillow S, McGuinness S, Parke R, Gilder E, Mccarthy L, Galt P, Taori G, Eliott S, Lamac T, Bailey M, Harley N, Barge D, Hodgson CL, Morganti-Kossmann MC, Pébay A, Conquest A, Archer JS, Bernard S, Stub D, Hart GK, and Bellomo R
- Subjects
- Analysis of Variance, Biomarkers blood, Female, Glasgow Coma Scale, Heart Arrest mortality, Heart Arrest physiopathology, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Heart Arrest therapy, Hypercapnia, Phosphopyruvate Hydratase blood, Respiration, Artificial methods, S100 Calcium Binding Protein beta Subunit blood
- Abstract
Background: In intensive care observational studies, hypercapnia after cardiac arrest (CA) is independently associated with improved neurological outcome. However, the safety and feasibility of delivering targeted therapeutic mild hypercapnia (TTMH) for such patients is untested., Methods: In a phase II safety and feasibility multi-centre, randomised controlled trial, we allocated ICU patients after CA to 24h of targeted normocapnia (TN) (PaCO2 35-45mmHg) or TTMH (PaCO2 50-55mmHg). The primary outcome was serum neuron specific enolase (NSE) and S100b protein concentrations over the first 72h assessed in the first 50 patients surviving to day three. Secondary end-points included global measure of function assessment at six months and mortality for all patients., Results: We enrolled 86 patients. Their median age was 61 years (58, 64 years) and 66 (79%) were male. Of these, 50 patients (58%) survived to day three for full biomarker assessment. NSE concentrations increased in the TTMH group (p=0.02) and TN group (p=0.005) over time, with the increase being significantly more pronounced in the TN group (p(interaction)=0.04). S100b concentrations decreased over time in the TTMH group (p<0.001) but not in the TN group (p=0.68). However, the S100b change over time did not differ between the groups (p(interaction)=0.23). At six months, 23 (59%) TTMH patients had good functional recovery compared with 18 (46%) TN patients. Hospital mortality occurred in 11 (26%) TTMH patients and 15 (37%) TN patients (p=0.31)., Conclusions: In CA patients admitted to the ICU, TTMH was feasible, appeared safe and attenuated the release of NSE compared with TN. These findings justify further investigation of this novel treatment., (Copyright © 2016. Published by Elsevier Ireland Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
39. Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliability.
- Author
-
Ridgeon E, Bellomo R, Myburgh J, Saxena M, Weatherall M, Jahan R, Arawwawala D, Bell S, Butt W, Camsooksai J, Carle C, Cheng A, Cirstea E, Cohen J, Cranshaw J, Delaney A, Eastwood G, Eliott S, Franke U, Gantner D, Green C, Howard-Griffin R, Inskip D, Litton E, MacIsaac C, McCairn A, Mahambrey T, Moondi P, Newby L, O'Connor S, Pegg C, Pope A, Reschreiter H, Richards B, Robertson M, Rodgers H, Shehabi Y, Smith I, Smith J, Smith N, Tilsley A, Whitehead C, Willett E, Wong K, Woodford C, Wright S, and Young P
- Subjects
- Australia, Humans, New Zealand, Reproducibility of Results, United Kingdom, Cause of Death, Critical Care
- Abstract
Objective: Trials in critical care have previously used unvalidated systems to classify cause of death. We aimed to provide initial validation of a method to classify cause of death in intensive care unit patients., Design, Setting and Participants: One hundred case scenarios of patients who died in an ICU were presented online to raters, who were asked to select a proximate and an underlying cause of death for each, using the ICU Deaths Classification and Reason (ICU-DECLARE) system. We evaluated two methods of categorising proximate cause of death (designated Lists A and B) and one method of categorising underlying cause of death. Raters were ICU specialists and research coordinators from Australia, New Zealand and the United Kingdom., Main Outcome Measures: Inter-rater reliability, as measured by the Fleiss multirater kappa, and the median proportion of raters choosing the most likely diagnosis (defined as the most popular classification choice in each case)., Results: Across all raters and cases, for proximate cause of death List A, kappa was 0.54 (95% CI, 0.49-0.60), and for proximate cause of death List B, kappa was 0.58 (95% CI, 0.53-0.63). For the underlying cause of death, kappa was 0.48 (95% CI, 0.44-0.53). The median proportion of raters choosing the most likely diagnosis for proximate cause of death, List A, was 77.5% (interquartile range [IQR], 60.0%-93.8%), and the median proportion choosing the most likely diagnosis for proximate cause of death, List B, was 82.5% (IQR, 60.0%-92.5%). The median proportion choosing the most likely diagnosis for underlying cause was 65.0% (IQR, 50.0%-81.3%). Kappa and median agreement were similar between countries. ICU specialists showed higher kappa and median agreement than research coordinators., Conclusions: The ICU-DECLARE system allowed ICU doctors to classify the proximate cause of death of patients who died in the ICU with substantial reliability.
- Published
- 2016
40. A national survey of Australian Intensive Care Unit (ICU) Liaison Nurse (LN) services.
- Author
-
Eliott S, Chaboyer W, Ernest D, Doric A, and Endacott R
- Subjects
- Australia, Humans, Patient Care Team, Surveys and Questionnaires, Critical Care Nursing, Nurse's Role, Nursing Staff, Hospital organization & administration
- Abstract
Background: The Intensive Care Unit (ICU) Liaison Nurses (LNs) emerged as a member of the multidisciplinary team to: assist in the transition of patients from ICU to the ward, respond to the deteriorating patient in an appropriate and timely manner, and in some instances act as an integral member of Rapid Response Teams (RRT)., Purpose: To identify the common core aspects and diversity within the ICU LN role across Australia and to determine whether the ICU LN hours of operation and the participation in MET teams has any impact on the activities undertaken by the ICU LN., Method: This descriptive survey of 152 Australian ICUs was conducted in April 2010. The Advanced Practice Nurse (APN) framework was used to develop the survey instrument, which comprised of four scales, education (5 items), collaboration (6 items), practice (8 items) research and quality (6 items) and a number of demographic questions. Descriptive statistics (mean, standard deviation (SD), median, interquartile ranges (IQR) and frequency) were used to summarise the data. Student's t-tests and Pearson's correlations were used to test the hypotheses., Results: Surveys were received from 113 hospitals (55 metropolitan, 58 regional): a 74% response rate. ICU LN services operated in 31 (27%) of these hospitals. LN services tended to operate in larger hospitals with higher ICU admission rates. The median weekly hours of operation was 56 (IQR 30; range 7-157), delivered by a median of 1.4 (IQR 0.9; range 0.0-4.2) Full Time Equivalent (FTE) staff. The median weekly patient visits made by the LN was 25 (IQR 44; range 2-145). The LN was reported to be a member of the Medical Emergency Team (MET) in 17 (68%) of the 25 hospitals that provided both MET and ICU LN services. The ICU LN activities were grouped under four key Advanced Practice Nurse (APN) domains: education, collaboration, practice and research/quality. Mean scale scores were calculated for each APN domain. The ICU LN reported being involved in activities associated with all four APN domains, and more frequently they were involved in education and expert practice during their daily work. Neither the presence of a MET nor the weekly operational hours of the LN service significantly affected the key activities undertaken by ICU LNs (education, collaboration, practice, research and quality)., Conclusion: Whilst many hospitals across Australia have introduced an ICU LN service, the staffing, hours of service, job classifications, reporting lines, referral processes and APN activities undertaken by the ICU LN, vary between hospitals, highlighting the diverse nature of ICU LN services across Australia., (Copyright © 2012 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
41. Bedside nurse-patient interactions do not reliably detect delirium: an observational study.
- Author
-
Mistarz R, Eliott S, Whitfield A, and Ernest D
- Subjects
- APACHE, Adult, Aged, Aged, 80 and over, Female, Hospitals, University, Humans, Male, Middle Aged, Observation, Predictive Value of Tests, Sensitivity and Specificity, Delirium diagnosis, Delirium nursing, Intensive Care Units, Nurse-Patient Relations, Nursing Assessment
- Abstract
Unlabelled: Delirium is an acute, reversible and fluctuating central nervous system dysfunction with an organic cause, and is associated with substantial morbidity and mortality. Many recent studies have shown that delirium is highly prevalent in the Intensive Care Unit (ICU) population. Despite its seriousness; delirium in the ICU is under recognized by bedside nurses., Objective: To determine if routine bedside nurse-patient interactions enable the detection of delirium., Method: We performed a single center observational study, in a 12 bed general Intensive Care Unit. Bedside nurses were asked to assess patients for delirium during routine patient care throughout their shift. This assessment was then compared to an independent assessment using the Confusion Assessment Method - ICU (CAM-ICU) performed by a nurse trained in this delirium detection tool., Results: We analysed the results of 35 matched assessments performed on 35 patients. The presence of delirium was identified by the bedside nurse in 27% of CAM-ICU delirium positive assessments, whereas the absence of delirium was identified by the bedside nurse in 92% of CAM-ICU delirium negative assessments., Conclusion: There was a significant discrepancy between the ICU bedside nurses' assessment of delirium and the independent formal delirium assessment utilizing the CAM-ICU. We concluded that routine bedside nursing patient interaction do not reliably detect delirium in a critically ill patient., (Copyright © 2011 Australian College of Critical Care Nurses Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
42. Length regulation in the Dictyostelium discoideum slug is a late event.
- Author
-
Breen EJ, Eliott S, Vardy PH, White A, and Williams KL
- Subjects
- Animals, Dictyostelium physiology, Morphogenesis, Movement, Videotape Recording, Dictyostelium growth & development
- Abstract
Time-lapse video light microscopy was used to study the emergence and maturation of the migratory slug from a D. discoideum aggregate. The anterior part, the tip of this simple multicellular organism, establishes migration prior to the definition of the rear, and hence the length of the slug. It was found that newly formed slugs of wild-type strain WS380B can reach lengths greater than 1 cm, yet mature slugs of this strain are rarely longer than 2-3 mumm. Often the tip extended out of the aggregation mound upon an arching pillar of cells. After the tip first touched the substratum, it commenced migration with a rapid succession of movement steps. Here we show that at the initiation of migration, a differential rate of cell movement along the developing slug axis results in a series of complicated changes, before the stable and mature shape of the slug is formed. Our results lead to new conclusions about D. discoideum slug formation and shape maintenance. Evidence is presented for regulation of slug length.
- Published
- 1992
- Full Text
- View/download PDF
43. [The day the students came].
- Author
-
Eliott S
- Subjects
- Students, Nursing
- Published
- 1969
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.